IN8bio Ownership | Who Owns IN8bio?


OverviewForecastFinancialsChart

IN8bio Ownership Summary


IN8bio is owned by 0.01% institutional investors, 5.44% insiders, and 94.55% retail investors. Alyeska investment group is the largest institutional shareholder, holding 21.59% of INAB shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 5.91% of its assets in IN8bio shares.

INAB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockIN8bio0.01%5.44%94.55%
SectorHealthcare Stocks 232.80%10.63%-143.43%
IndustryBiotech Stocks 379.48%10.37%-289.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Alyeska investment group944.32K21.59%$1.40M
Franklin resources914.53K20.91%$1.35M
683 capital management724.64K16.57%$1.07M
Stonepine capital management663.41K15.17%$981.85K
Bios capital management, lp167.81K3.84%$248.35K
Geode capital management86.24K1.97%$127.64K
Vanguard fiduciary trust43.57K1.00%$64.70K
Captrust financial advisors33.30K0.76%$49.28K
Oppenheimer24.03K0.55%$35.57K
Texas capital bank wealth management services23.75K0.54%$35.15K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp167.81K0.47%$248.35K
Stonepine capital management663.41K0.39%$981.85K
683 capital management724.64K0.06%$1.07M
Alyeska investment group944.32K0.00%$1.40M
Texas capital bank wealth management services23.75K0.00%$35.15K
Bridgeway capital management103.30K0.00%$87.44K
Oppenheimer24.03K0.00%$35.57K
Xtx topco12.43K0.00%$18.40K
Franklin resources914.53K0.00%$1.35M
Captrust financial advisors33.30K0.00%$49.28K

Top Buyers

HolderShares% AssetsChange
Stonepine capital management663.41K0.39%498.52K
Geode capital management86.24K-65.27K
Vanguard fiduciary trust43.57K-43.57K
Blackrock57.08K-28.88K
Oppenheimer24.03K0.00%24.03K

Top Sellers

HolderShares% AssetsChange
Vanguard group---1.80M
Aigh capital management---1.45M
Ensign peak advisors---829.18K
Sigma planning---700.68K
Stonegate investment group---180.00K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust43.57K-43.57K$64.70K
Oppenheimer24.03K0.00%24.03K$35.57K

Sold Out

HolderChange
Morgan stanley-34.00
Jpmorgan chase-102.00
Wells fargo & company/mn-247.00
Westside investment management-2.00K
Vontobel-10.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20251-286,664--0.01%----100.00%
Jun 30, 20251-96.43%286,664-98.68%-2266.86%--100.00%1-85.71%
Mar 31, 20252812.00%21,678,562-27.81%250.64%12-25.00%775.00%
Dec 31, 202423-8.00%29,929,085292.48%6324.36%1633.33%3-50.00%
Sep 30, 202423-8.00%7,560,808-2.34%155.00%11-620.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Franklin Biotechnology Discv A(acc)USD582.43K5.91%-
Franklin Biotechnology Discovery A332.08K3.37%-
Vanguard US Total Market Shares ETF952.49K1.17%-2.00
Vanguard Institutional Extnd Mkt Idx Tr88.86K0.90%69.39K
Fidelity Extended Market Index63.84K0.65%46.94K
Bridgeway Ultra-Small Company Market98.00K0.21%-
NT Ext Equity Mkt Idx Fd - L13.41K0.14%-
NT Ext Equity Mkt Index Fund - Lending13.41K0.14%-
Northern Trust Extended Eq Market Idx13.41K0.14%11.30K
Spartan Extended Market Index Pool F8.84K0.09%8.84K

Recent Insider Transactions


DateNameRoleActivityValue
May 02, 2025Kreis Leslie W.-Buy$114.85
Oct 04, 2024Kreis Leslie W.-Buy$191.44K
Oct 04, 2024Kreis Leslie W.-Buy$70.90
Oct 04, 2024Fletcher Aaron G.L.-Buy$70.90
Oct 04, 2024Fletcher Aaron G.L.-Buy$191.44K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q21-
2025 Q1--
2024 Q46-

INAB Ownership FAQ


Who Owns IN8bio?

IN8bio shareholders are primarily institutional investors at 0.01%, followed by 5.44% insiders and 94.55% retail investors. The average institutional ownership in IN8bio's industry, Biotech Stocks , is 379.48%, which IN8bio falls below.

Who owns the most shares of IN8bio?

IN8bio’s largest shareholders are Alyeska investment group (944.32K shares, 21.59%), Franklin resources (914.53K shares, 20.91%), and 683 capital management (724.64K shares, 16.57%). Together, they hold 59.06% of IN8bio’s total shares outstanding.

Does Blackrock own IN8bio?

BlackRock is not among the top 10 institutional shareholders of IN8bio.

Who is IN8bio’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is IN8bio’s biggest shareholder by percentage of total assets invested, with 0.47% of its assets in 167.8K IN8bio shares, valued at 248.35K$.

Who is the top mutual fund holder of IN8bio shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of IN8bio shares, with 5.91% of its total shares outstanding invested in 582.43K IN8bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools